PepGen develops treatments for severe neuromuscular diseases, starting with myotonic dystrophy type 1. It last closed at $3.78 on Nov 20, down 3.82% on the day. The next earnings report for PEPG is expected around Wed, Mar 3, 2027, after the close. For the quarter ended Sep 2026, PEPG reported EPS of -$0.28. Over its last 8 reports the stock moved an average of 31.5% the session after earnings. Over the last 12 months PEPG insiders bought $43.1M of stock on the open market and sold $59K, according to SEC Form 4 filings.
AI Auto Pilots
Is PEPG in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PEPG.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PEPGStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PEPG · as of the Nov 20 close · updated each morning
Uptrend
The stock is 13% above its 20 day and 24% above its 50 day average. It is 23% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 56). The nearest support is the Pivot S1 at $3.65, and the nearest resistance the Pivot at $3.81.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 13.7%/day
Key levels
$7.8052 week high+106.3%
$6.45Swing high (Nov 10)+70.6%
$3.95Pivot R1+4.5%
$3.81Pivot+0.8%
$3.78Last close
$3.65Pivot S1−3.4%
$3.62Swing low (Nov 17)−4.2%
$3.2920 day average−13.0%
$2.91200 day average−23.0%
$2.8850 day average−23.8%
$2.72100 day average−28.0%
$1.3152 week low−65.3%
Indicators
RSI (14)
56.46
Middle of its range
Neutral
MACD
0.39
Above its signal line
Bullish
Stochastic
38.5
Middle of its range
Neutral
ADX (14)
27.0
Trending up
Williams %R
-63.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
30.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+53.0%
Change over 10 sessions
Bullish
ATR (14)
$0.52
Typical daily range, 13.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Bounce inside a longer downtrend
Short trendBullish
Long trendBearish
MomentumStrong
StretchNormal
VolatilityNormal, 20.6%/day
Key levels
$7.8052 week high+106.3%
$6.45Swing high (Nov 10)+70.6%
$3.95Pivot R1+4.5%
$3.81Pivot+0.8%
$3.78Last close
$3.65Pivot S1−3.4%
$3.62Swing low (Nov 17)−4.2%
$3.2920 day average−13.0%
$2.91200 day average−23.0%
$2.8850 day average−23.8%
$2.72100 day average−28.0%
$1.3152 week low−65.3%
Indicators
RSI (14)
59.71
Middle of its range
Neutral
MACD
0.13
Above its signal line
Bullish
Stochastic
42.2
Middle of its range
Neutral
ADX (14)
20.8
Weak trend
Williams %R
-63.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
167.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+26.9%
Change over 10 sessions
Bullish
ATR (14)
$0.78
Typical daily range, 20.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Below
What happened before, for PEPG
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PEPG did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PEPG usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PEPGHow many large options trades hit PEPG, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PEPG in the last 90 days.
From SEC Form 4 filings by PEPG's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PEPG is in one of them and how their past PEPG trades turned out.
PepGen is a biotechnology company based in Boston, Massachusetts, that develops treatments for severe neuromuscular and neurologic diseases. Its lead candidate, PGN-EDODM1, is being developed for myotonic dystrophy type 1, a multi-system muscle disease with no approved therapies. The company's proprietary delivery platform uses peptides designed to carry short strands of genetic material into muscle and other cells, aiming to reach the cell nucleus. Its treatments remain in clinical trials and are intended for patients with these conditions.